The Summary
This secondary analysis of two randomized controlled trials evaluated how baseline inflammation affects vitamin D absorption. Researchers matched 11 adults with elevated levels of the inflammatory cytokine IL-6 to 22 matched controls with non-elevated IL-6. All participants received 4,000 or 8,000 IU/day of vitamin D. While both groups achieved similar vitamin D levels by day 28, those with high baseline inflammation showed a significantly lower increase in blood vitamin D levels at day 7. The blunting effect of inflammation on vitamin D uptake is temporary.
Why this is interesting
Normally, we expect vitamin D levels to rise predictably with supplementation. This study reveals a crucial nuance: systemic inflammation (indicated by elevated IL-6) temporarily hinders this process. For readers, this means if you are dealing with an inflammatory condition like osteoarthritis or an infection, your body may take longer to register the benefits of vitamin D. It suggests that monitoring inflammation alongside vitamin levels could help doctors better tailor the timing and dosage of nutrients, ensuring your body actually absorbs what you give it.